Globally, 23% of new hepatitis c infections are a result of injecting drugs. Yet global coverage of harm reduction programmes for people who inject drugs, including needle and syringe programmes, is less than 10%.
The global movement to eliminate viral hepatitis by 2030.
What is NOhep?
NOhep unites people around the world behind a shared goal: the elimination of viral hepatitis. With one voice we demand action, we demand change and we demand that millions of people around the world are given a chance to live a life free of this disease!
Why do we need NOhep?
Viral hepatitis is one of the leading causes of death globally, accounting for more deaths per year than HIV/AIDS or malaria.
Despite killing 1.4 million people every year, the response to viral hepatitis is critically under-funded and widely overlooked by international funders and development partners.
290 million people are completely unaware they are living with the virus.
This puts them at risk of developing fatal liver disease or unknowingly passing the virus on to others.
A human rights injustice
People living with viral hepatitis often face discrimination and stigma which impacts their health, employment and relationships. Those hit hardest by the disease are often from marginalised communities, including refugees, indigenous peoples, people who inject drugs and LGBT people, and face multiple barriers to prevention, diagnosis, and treatment services.
In 2016, every country in the world committed to eliminating viral hepatitis by 2030
However, few countries are on track to meet the World Health Organization’s targets.
Now, we must act to make sure elimination becomes a reality
Get involved by:
- Joining our global movement
- Advocating to your government for NOhep
- Spreading the word on social media using #NOhep
2030 elimination targets
Globally, only around 10 per cent of people living with viral hepatitis receive life-saving medication.
Worldwide, only 20% of people living with hepatitis C and 9% of those with hepatitis B are aware of their condition.
One in three low-income countries do not routinely screen blood, greatly increasing the chances of the virus being spread.
Effective vaccines exist to prevent viral hepatitis B, a silent killer chronically infecting approximately 257 million people. At the moment, only 39% of infants receive birth-dose vaccinations.
Today, approximately 1.4 million people die as a result of hepatitis B and C each year.
Find out more about the different types of hepatitis and how they are prevented, transmitted and treated
Fight for elimination in your community. Fight for your government to prioritise elimination efforts. Fight for the elimination of viral hepatitis by 2030!
Join 5,000 dedicated global activists and play your part to help eliminate viral hepatitis by 2030